XAI Madison Equity Premium Income Fund Will Host its Q1 2025 Quarterly Webinar on June 11, 2025
CHICAGO, June 06, 2025 ( GLOBE NEWSWIRE ) -- XAI Madison Equity Premium Income Fund ( NYSE: MCN ) ( the "Fund" ) today announced that it plans to host the Fund's Quarterly Webinar on June 11, 2025 at 11:00 am ( Eastern Time ) . Jared Hagen, Vice President at XA Investments ( "XAI" ) , will ...
Fly Play hf.: Strong Bookings Signal Payoff from Leisure Strategy
PLAY carried 117,199 passengers in May 2025, compared to 146,692 passengers in May 2024, reflecting a 14.0% reduction in PLAY's capacity for the month. This reduction is the result of the company's decision to lease aircraft to SkyUp through its Maltese AOC and put more emphasis on the ...
QuisLex President and CEO Sirisha Gummaregula Named a Top Woman Leader of 2025 by Women We Admire
NEW YORK, June 06, 2025 ( GLOBE NEWSWIRE ) -- QuisLex, a leading alternative legal services provider and pioneer in the industry, is proud to announce its president and chief executive officer Sirisha Gummaregula has been recognized as one of the Top Women Leaders of 2025 by Women We Admire.
Why QXO Stock Is Shooting Higher Today
A Wall Street analyst has high hopes for building products distributor QXO ( NYSE: QXO ) , and investors are taking note.Shares of QXO traded up 12% as of 10:30 a.m. ET after Wolfe Research set a target price for the stock that is more than 150% above where the shares closed Thursday.Image ...
Huize ( HUIZ ) Q1 2025 Earnings Call Transcript
Image source: The Motley Fool.Need a quote from one of our analysts? Email pr@fool.comHuize ( NASDAQ:HUIZ ) achieved a sequential rise in premium volume for Q1 2025, marked by cost discipline, customer base expansion, and further integration of AI across business processes.
Braze Analysts Slash Their Forecasts After Q1 Earnings - Braze ( NASDAQ:BRZE )
Braze, Inc. BRZE reported better-than-expected earnings for the first quarter on Thursday. The company posted quarterly earnings of 7 cents per share which beat the analyst consensus estimate of 5 cents per share.
Arcutis Unveils Long-Term Efficacy, Safety For Zoryve Cream In Pediatric Patients With Atopic Dermatitis - Arcutis Biotherapeutics ( NASDAQ:ARQT )
Zoryve cream helped 63.1% of children aged 2-5 reach vIGA-AD 0/1 after 56 weeks. Only 2.5% of kids aged 2-5 experienced treatment-related side effects in the study. Ready to turn the market's comeback into steady cash flow? Grab the top 3 stocks to buy right here. Arcutis Biotherapeutics, Inc.
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Teck Resources ( NYSE:TECK )
Teck Resources TECK has outperformed the market over the past 5 years by 13.46% on an annualized basis producing an average annual return of 26.78%. Currently, Teck Resources has a market capitalization of $19.29 billion.
IDEX Biometrics ASA: Final result of the Subsequent Offering
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ...




